Document Detail

Effect of Hypoglycemia on Brain Structure in People With Type 2 Diabetes: Epidemiological Analysis of the ACCORD-MIND MRI Trial.
MedLine Citation:
PMID:  25267796     Owner:  NLM     Status:  In-Data-Review    
OBJECTIVE: The effect of hypoglycemia related to treatment of type 2 diabetes mellitus (T2DM) on brain structure remains unclear. We aimed to assess whether symptomatic severe hypoglycemia is associated with brain atrophy and/or white matter abnormalities.
RESEARCH DESIGN AND METHODS: We included T2DM participants with brain MRI from the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) trial. Symptomatic severe hypoglycemia was defined as blood glucose <2.8 mmol/L or symptoms resolved with treatments that required the assistance of another person or medical assistance (hypoglycemia requiring assistance [HA]). Standardized brain MRI was performed at baseline and at 40 months. Total brain volume (TBV) and abnormal white matter (AWM) volume were calculated using an automated computer algorithm. Brain MRI scans of hypoglycemic participants were also reviewed for local disease.
RESULTS: Of the 503 T2DM participants (mean age, 62 years) with successful baseline and 40-month brain MRI, 28 had at least one HA episode during the 40-month follow-up. Compared with participants without HA, those with HA had marginally significant less atrophy (less decrease in TBV) from baseline to 40 months (-9.55 [95% CI -15.21, -3.90] vs. -15.38 [95% CI -16.64, -14.12], P = 0.051), and no significant increase of AWM volume (2.06 [95% CI 1.71, 2.49] vs. 1.84 [95% CI 1.76, 1.91], P = 0.247). In addition, no unexpected local signal changes or volume loss were seen on hypoglycemic participants' brain MRI scans.
CONCLUSIONS: Our study suggests that hypoglycemia related to T2DM treatment may not accentuate brain pathology, specifically brain atrophy or white matter abnormalities.
Zi Zhang; James Lovato; Harsha Battapady; Christos Davatzikos; Hertzel C Gerstein; Faramarz Ismail-Beigi; Lenore J Launer; Anne Murray; Zubin Punthakee; Amilcar A Tirado; Jeff Williamson; R Nick Bryan; Michael E Miller
Related Documents :
17287416 - Tissue inhibitor of metalloproteinase-1 predicts adiposity in humans.
25452366 - The influence of diabetes mellitus on the post-operative outcome of elective primary to...
25411606 - Association of hypertension status and cardiovascular risks with sympathovagal imbalanc...
7631766 - Central adiposity and its metabolic correlates in obese adolescent girls.
24281606 - Local use of insulin in wounds of diabetic patients: higher temperature, fibrosis, and ...
20938636 - Impaired insulin-induced site-specific phosphorylation of tbc1 domain family, member 4 ...
Publication Detail:
Type:  Journal Article     Date:  2014-09-29
Journal Detail:
Title:  Diabetes care     Volume:  37     ISSN:  1935-5548     ISO Abbreviation:  Diabetes Care     Publication Date:  2014 Dec 
Date Detail:
Created Date:  2014-11-21     Completed Date:  -     Revised Date:  2014-12-06    
Medline Journal Info:
Nlm Unique ID:  7805975     Medline TA:  Diabetes Care     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3279-85     Citation Subset:  IM    
Copyright Information:
© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  CarrotDB: a genomic and transcriptomic database for carrot.
Next Document:  Increased Reactive Oxygen Species, Metabolic Maladaptation, and Autophagy Contribute to Pulmonary Ar...